Data Foundry

Drug recalls 2023

Norepinephrine 8 mg per 250 mL — Class II drug recall D-0932-2023

Terminated recall by SterRx, LLC, reported 2023-07-26, distributed nationwide. Lack of Assurance of Sterility

Recall numberD-0932-2023
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmSterRx, LLC, Plattsburgh, NY, United States
Recall initiated2023-07-07
Classified2023-07-19
Reported by FDA2023-07-26
Terminated2024-07-08
DistributedNationwide (US)
Quantity125,598 bags
Reason classessterility
NDC70324-0577-01
Lot numbers490071, 490089, 490118, 490126, 490169, 491276, 491284, 491612, 497467, 497475, 499104, 499112, 499121, 499278, 499358, 502019, 502027, 502035, 503513, 504217
Expiration dates2023-07-30, 2023-08-04, 2023-08-05, 2023-08-10, 2023-08-11, 2023-08-12, 2023-08-18, 2023-12-08, 2023-12-09, 2024-01-18, 2024-01-19, 2024-01-20, 2024-01-21, 2024-03-24, 2024-03-29, 2024-04-05, 2024-04-18, 2024-04-20

Product

Norepinephrine 8 mg per 250 mL (32 mcg per mL) in 0.9% Sodium Chloride, 250 mL Single Dose bag, packaged in 250 mL x 12 units per case, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903, NDC 70324-577-01.

Reason for recall

Lack of Assurance of Sterility

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0932-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.